| Articolul precedent |
| Articolul urmator |
 570 0 |
 SM ISO690:2012ADELUNG, Rainer. Oxide semiconductors as antiviral agents: herpes therapy from lab to pharmacy. In: Nanotechnologies and Biomedical Engineering, Ed. 3, 23-26 septembrie 2015, Chișinău. Springer, 2015, Editia 3, p. 46. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Nanotechnologies and Biomedical Engineering Editia 3, 2015 |
||||||
|
Conferința "International Conference on Nanotechnologies and Biomedical Engineering" 3, Chișinău, Moldova, 23-26 septembrie 2015 | ||||||
|
||||||
| Pag. 46-46 | ||||||
|
||||||
| Rezumat | ||||||
Herpes simplex viruses (HSV) establish lifelong infections, and the virus cannot yet be eradicated from the body. The HSV-2 type is one of the most frequent sexually transmitted infections worldwide with global estimates of 536 million infected people and an annual incidence of 23.6 million cases [1]. In this presentation, the antiviral potential of oxide semiconductors as antiviral agents will be discussed [2-4]. Oxygen vacancies are employed as adhesion sites of glycoproteins on the surface of the capsid and bind the virus effectively. It will be shown that oxid semiconductors can have a prophylactic, therapeutic as well as neutralizing effect. It will be explained how irradiation of UV-light can even increase the antiviral activity. The cytotoxic effects [4] of the micro-crystalline material are discussed as well as how the material could be brought from lab into pharmacies. |
||||||
|
|
|
|
